Actigraphy devices Market to Reach USD 16,041.9 million by 2032, Growing at a CAGR of 25.97% says Credence Research

Market Outlook

The actigraphy devices market is witnessing exponential growth as the healthcare industry shifts towards remote patient monitoring and wearable medical devices. In 2024, the market size stands at USD 2,530 million and is projected to surge to USD 16,041.9 million by 2032, registering a remarkable CAGR of 25.97%. The increasing prevalence of sleep disorders such as insomnia, obstructive sleep apnea, and circadian rhythm disorders is fueling the demand for non-invasive, real-time monitoring solutions.

Actigraphy devices, primarily used to track and analyze sleep-wake cycles and physical activity patterns, have become pivotal in clinical and home-based applications. These devices provide clinicians with objective sleep data, empowering early diagnosis and continuous patient monitoring without the need for cumbersome polysomnography equipment. Furthermore, with rising awareness around sleep health and its direct link to chronic diseases, patients increasingly prefer actigraphy solutions for at-home diagnostics.

Compared to traditional methods, actigraphy offers cost-effectiveness, user-friendly interfaces, and long-term monitoring capability. The COVID-19 pandemic accelerated adoption as remote healthcare solutions became critical. Additionally, technological advancements, such as integration with AI and biosensors, have enhanced data accuracy and analysis capabilities. Overall, the market is becoming an indispensable part of healthcare infrastructure globally.

Preview the report with a detailed sample and understand how it can benefit your business strategy. Request a free sample today https://www.credenceresearch.com/report/actigraphy-devices-market

Market Drivers

Rising Prevalence of Sleep Disorders
The growing global prevalence of sleep disorders such as insomnia, sleep apnea, and circadian rhythm disruptions is a primary market driver. According to recent health surveys, over 1 in 3 adults report insufficient sleep globally. Actigraphy devices allow clinicians to objectively assess these conditions, reducing reliance on subjective patient reports and traditional sleep studies, which are more expensive and less accessible.
This rising trend is largely attributed to modern lifestyle factors, including work-related stress, irregular sleep schedules, and increased screen time. Healthcare professionals are now focusing on early diagnosis to prevent chronic health issues like heart disease and depression associated with poor sleep. As public awareness increases, patients are seeking reliable, at-home solutions for consistent sleep monitoring.

Technological Advancements in Wearable Devices
Continuous innovation in wearable technology significantly drives the market. Modern actigraphy devices are now equipped with advanced biosensors and artificial intelligence algorithms that enhance data precision and interpretation. For instance, devices like Apple Watch now offer sleep apnea notifications, making health monitoring seamless and user-friendly.
These technological improvements reduce manual interpretation errors and provide real-time analytics to both users and healthcare providers. Moreover, the integration of cloud-based platforms facilitates remote data storage and sharing, ensuring comprehensive patient monitoring. Companies increasingly focus on miniaturization and battery life, improving device convenience and long-term use.

Shift Towards Remote Patient Monitoring
There is an ongoing paradigm shift in healthcare towards remote patient monitoring, especially post-pandemic. Healthcare providers and patients now prioritize solutions that allow continuous monitoring without hospital visits. Actigraphy devices enable long-term tracking of sleep and activity patterns, facilitating better management of chronic conditions while improving patient compliance and comfort.
This shift not only reduces healthcare costs but also addresses the shortage of medical professionals by empowering patients with self-monitoring tools. Additionally, the convenience of remote solutions aligns with patient preference for non-invasive, on-the-go health devices. Digital health platforms now allow integration with electronic medical records (EMR), streamlining clinical workflows.

Cost-Effectiveness Compared to Polysomnography
Actigraphy devices present a more affordable and accessible alternative to polysomnography (PSG). While PSG is the gold standard for sleep studies, its high cost and need for clinical environments limit its usage. Actigraphy offers a non-invasive, cost-effective solution that provides clinicians with continuous data over extended periods, making it a preferred choice for both hospitals and home-based care.
This affordability encourages broader adoption in outpatient clinics and home care, especially in regions with limited medical infrastructure. Additionally, patients appreciate the convenience of using actigraphy devices without disrupting their daily life. Insurance providers are also starting to recognize actigraphy as a reimbursable diagnostic tool, which is expected to boost further adoption.

Market Challenges

Regulatory Compliance Complexity
Navigating global regulatory frameworks remains a significant barrier for market players. Actigraphy devices are classified as medical devices in most regions, requiring rigorous FDA or CE approval. The long approval cycles and stringent testing protocols slow down time-to-market for innovative solutions.
These regulatory hurdles increase development costs and can discourage startups from entering the market. Moreover, inconsistent regulations across countries complicate global market expansion strategies. Companies must maintain continuous compliance monitoring to meet evolving regional standards.

Data Privacy and Security Concerns
As actigraphy devices collect sensitive health data, concerns around data privacy and cybersecurity are critical challenges. With an increasing number of connected devices, ensuring compliance with data protection regulations such as HIPAA (US) and GDPR (EU) poses additional costs and technical hurdles.
Consumers are increasingly aware of data breaches, raising reluctance to adopt connected health devices. Manufacturers must implement strong encryption and authentication protocols to build user trust. Security vulnerabilities in connected medical devices may attract cyber-attacks, creating liability risks.

Market Fragmentation and Intense Competition
The actigraphy devices market is highly fragmented, with many small and large players competing. This leads to price wars, eroded profit margins, and challenges in differentiation. Moreover, tech giants like Apple and Fitbit introduce competitive smartwatches with sleep monitoring features, blurring the lines between medical and consumer-grade devices.
Smaller players struggle to invest in R&D, limiting their ability to innovate at scale. Market saturation in developed regions makes gaining market share increasingly difficult. Companies must now focus on unique value propositions such as advanced analytics or clinical partnerships to stand out.

Limited Awareness in Developing Regions
Despite significant growth in North America and Europe, adoption in developing regions remains low due to a lack of awareness, limited healthcare infrastructure, and affordability concerns. Market penetration strategies must overcome these challenges to unlock the untapped potential in Asia Pacific, Latin America, and the Middle East.
Low per capita healthcare spending and lack of trained medical personnel in these regions impede device adoption. Government healthcare programs are still evolving, with limited focus on preventive diagnostics like sleep monitoring. Collaborations with local health providers and cost-effective models could help accelerate adoption.

Market Opportunity

Integration with AI and Machine Learning
Advanced analytics powered by AI and machine learning offer new opportunities for actigraphy device manufacturers. These technologies improve the interpretation of large-scale data sets, enabling predictive analytics and personalized health recommendations, thus increasing the clinical relevance of actigraphy.
Real-time anomaly detection algorithms can alert clinicians of irregular sleep patterns or potential health risks, enhancing preventive care. AI enables adaptive learning, refining diagnostic accuracy over time as more data is collected. Integration with virtual assistants may further personalize patient interactions.

Expansion of Telehealth Services
The rapid adoption of telehealth solutions creates an opportunity for actigraphy devices as complementary diagnostic tools. Healthcare providers are actively integrating wearable actigraphy devices into telemedicine platforms, allowing remote patient diagnosis, treatment adjustments, and follow-up care.
Patients appreciate the convenience of receiving medical consultations without hospital visits, increasing the demand for connected devices. Insurance companies are expanding coverage for telehealth services, including remote diagnostics. Telehealth platforms now often bundle actigraphy with other connected devices for comprehensive remote monitoring.

Emerging Markets with Growing Healthcare Infrastructure
Regions such as India, Brazil, and South Africa are witnessing an upsurge in healthcare investments. As awareness around sleep health grows and healthcare infrastructure improves, these markets present high growth potential for actigraphy device manufacturers, especially when distributed via cost-effective channels.
Healthcare reforms aimed at digitalization further accelerate this growth. Government subsidies and local partnerships help reduce entry barriers for foreign companies. Expanding rural healthcare networks provide additional opportunities to reach underserved populations.

Collaborations and Strategic Partnerships
Collaborations between device manufacturers and healthcare institutions, or software providers, are emerging as a major opportunity. For example, ActiGraph's acquisition of Biofourmis Connect in January 2025 unifies software and data platforms, enhancing its clinical research capabilities and strengthening its market position.
Partnerships with hospitals and clinics promote clinical validation of new devices. Co-development of next-gen analytics platforms enables end-to-end sleep monitoring solutions. Furthermore, industry-academia collaborations support innovative R&D projects, driving continuous advancement in device accuracy and clinical utility.

Market Segmentation

Based on Product
• Wearable actigraphy devices
• Handheld actigraphy devices

Based on Application
• Sleep disorders monitoring
• Circadian rhythm disorder monitoring
• Insomnia and restless leg syndrome diagnosis
• Other applications

Based on Distribution Channel
• Online
• Brick and mortar

Based on the Geography:

North America
• U.S.
• Canada
• Mexico

Europe
• UK
• France
• Germany
• Italy
• Spain
• Russia
• Belgium
• Netherlands
• Austria
• Sweden
• Poland
• Denmark
• Switzerland
• Rest of Europe

Asia Pacific
• China
• Japan
• South Korea
• India
• Thailand
• Indonesia
• Vietnam
• Malaysia
• Philippines
• Taiwan
• Rest of Asia Pacific

Latin America
• Brazil
• Argentina
• Peru
• Chile
• Colombia
• Rest of Latin America

Middle East & Africa
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Regional Analysis

North America
North America dominates the actigraphy devices market, accounting for a significant share. The U.S., in particular, leads the region due to advanced healthcare infrastructure, high awareness of sleep disorders, and a strong presence of key market players such as Fitbit and Apple. Rising geriatric population and increasing adoption of wearable health devices further propel market growth in this region.
The region benefits from established telehealth networks and favorable reimbursement policies, increasing adoption of remote monitoring solutions. Healthcare providers are quick to integrate new technologies due to strong regulatory frameworks and consumer trust in innovative devices. Technological partnerships between device manufacturers and hospitals further support market expansion.

Europe
Europe holds the second-largest market share, with countries like the UK, Germany, and France being major contributors. The region's strong regulatory framework and high R&D investments enable advanced product development and adoption. Recent trends include the integration of actigraphy devices with telehealth platforms for remote sleep disorder management.
Increasing investments in digital health infrastructure by governments bolster the market. High public awareness campaigns regarding sleep health are driving patient adoption of monitoring solutions. Furthermore, growing emphasis on preventive healthcare is encouraging hospitals and clinics to use actigraphy devices for routine check-ups.

Asia Pacific
The Asia Pacific region is emerging as a high-growth market due to rising healthcare awareness, increasing sleep disorder prevalence, and expanding healthcare infrastructure. Markets like China, India, and Japan are witnessing accelerated adoption. Affordable devices and increasing digital health investments are driving market penetration in this region.
Rapid urbanization and lifestyle changes contribute to a rising number of sleep disorder cases. Smartphone penetration and internet availability boost connected health device usage. Government initiatives to digitize healthcare systems provide a favorable environment for market growth.

Rest of the World (Latin America and MEA)
Latin America and Middle East & Africa remain relatively nascent markets but present immense growth opportunities. Government initiatives aimed at improving healthcare access and growing middle-class health consciousness are slowly increasing market adoption. Brazil and South Africa are key markets contributing to growth.
The presence of a large underserved population in rural areas presents long-term growth prospects. International players are adopting region-specific pricing strategies to improve affordability. Local partnerships and increasing awareness campaigns will be crucial to expanding market presence in the coming years.

Top Companies

• Apple
• Cleveland Medical Devices
• ResMed
• Garmin
• CamNtech
• Nox Medical
• Philips Healthcare
• Samsung
• Neurocare
• Cidelec
• Advanced Brain Monitoring
• ActiGraph
• Fitbit

Recent Developments

• In January 2025, ActiGraph expanded its portfolio by acquiring Biofourmis Connect, the life sciences division of Biofourmis, to unify software and data platforms and enhance clinical research across therapeutic areas.

• February 2025 witnessed PranaQ securing U.S. FDA 510(k) clearance for TipTraQ, a compact home sleep apnea test wearable. It leverages advanced biosensors and AI algorithms to detect sleep apnea and analyze sleep architecture with clinical-grade accuracy, worn on the fingertip.

• In September 2024, Apple upgraded its health ecosystem by adding new sleep monitoring features to the Apple Watch, including sleep apnea notifications, enhancing its clinical utility.

• July 2025 saw Fitbit updating the Charge 6 wearable, incorporating new watch faces and expanding compatibility with fitness platforms like Peloton and iFit, improving its market competitiveness.

Reasons to Purchase this Report:

• Gain in-depth insights into the market through both qualitative and quantitative analyses, incorporating economic and non-economic factors, with detailed segmentation and sub-segmentation by market value (USD Billion).

• Identify the fastest-growing regions and leading segments through analysis of geographic consumption trends and the key drivers or restraints affecting each market.

• Track the competitive landscape with updated rankings, recent product launches, strategic partnerships, business expansions, and acquisitions over the past five years.

• Access comprehensive profiles of key players, featuring company overviews, strategic insights, product benchmarking, and SWOT analyses to assess market positioning and competitive advantages.

• Explore current and projected market trends, including growth opportunities, key drivers, challenges, and limitations across developed and emerging economies.

• Leverage Porter's Five Forces analysis and Value Chain insights to evaluate competitive dynamics and market structure.

• Understand how the market is evolving and uncover future growth opportunities and emerging trends shaping the industry.

Related Reports -

Endoscope Reprocessing Market- https://www.credenceresearch.com/report/endoscope-reprocessing-device-market

Stent Retriever Market - https://www.credenceresearch.com/report/stent-retriever-market

Follow Us:

https://www.linkedin.com/company/credenceresearch/

https://www.facebook.com/CredenceResearch

Credence Research Europe LTD - 128 City Road, London, EC1V 2NX, UNITED KINGDOM

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 2000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives.

This release was published on openPR.